Julie Hambleton

Insider Reports History

Entity
Individual
Location
C/O Five Prime Therapeutics, Inc., Two Corporate Drive, South San Francisco, CA
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julie Hambleton:

Insider Reports Filed by Julie Hambleton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SWTX SpringWorks Therapeutics, Inc. Feb 10, 2025 3 -$286K 4 Feb 12, 2025 Director
IGMS IGM Biosciences, Inc. Jul 25, 2024 3 -$191K 4 Jul 29, 2024 Director
ERAS Erasca, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
SWTX SpringWorks Therapeutics, Inc. Jun 3, 2024 4 -$186K 4 Jun 5, 2024 Director
SWTX SpringWorks Therapeutics, Inc. May 16, 2024 2 $0 4 May 17, 2024 Director
IGMS IGM Biosciences, Inc. Mar 12, 2024 1 $0 4 Mar 14, 2024 Director
SWTX SpringWorks Therapeutics, Inc. Jul 19, 2023 1 -$70.9K 4 Jul 21, 2023 Director
ERAS Erasca, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
SWTX SpringWorks Therapeutics, Inc. Jun 20, 2023 1 -$64.6K 4 Jun 22, 2023 Director
SWTX SpringWorks Therapeutics, Inc. May 24, 2023 2 $0 4 May 25, 2023 Director
IGMS IGM Biosciences, Inc. Apr 4, 2023 1 $0 4 Apr 6, 2023 Director
SWTX SpringWorks Therapeutics, Inc. Mar 15, 2023 1 -$34.8K 4 Mar 16, 2023 Director
ERAS Erasca, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
SWTX SpringWorks Therapeutics, Inc. May 19, 2022 2 $0 4 May 20, 2022 Director
IGMS IGM Biosciences, Inc. Mar 12, 2022 1 $0 4 Mar 15, 2022 Director
IGMS IGM Biosciences, Inc. Aug 9, 2021 1 -$80K 4 Aug 11, 2021 Director
ERAS Erasca, Inc. Jul 20, 2021 1 $96K 4 Jul 20, 2021 Director
ERAS Erasca, Inc. Jul 15, 2021 0 $0 3 Jul 15, 2021 Director
IGMS IGM Biosciences, Inc. Jun 1, 2021 1 -$160K 4 Jun 3, 2021 Director
SWTX SpringWorks Therapeutics, Inc. May 20, 2021 2 $0 4 May 21, 2021 Director